ASCP Corner: Antipsychotic Polypharmacy, Part 1: Shotgun Approach or Targeted Cotreatment?
J Clin Psychiatry 2008;69(4):674-675
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
The combination of medications is common
in the management of many, if not
most, chronic disorders. Being among the
most severe mental disorders, schizophrenia
is predisposed to the concurrent use of
more than 1 medication. This article is the
first of 2 related CORNER articles that discuss
antipsychotic polypharmacy in the
treatment of schizophrenia.